We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+10.03%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$39.6B
AUM Growth
+$2.78B
(+7.6%)
Cap. Flow
-$224M
Cap. Flow
% of AUM
-0.57%
Top 10 Holdings %
Top 10 Hldgs %
25.25%
Holding
1,779
New
108
Increased
532
Reduced
495
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$141M |
| 2 |
Meta Platforms (Facebook)
META
|
+$55.8M |
| 3 |
Analog Devices
ADI
|
+$48.7M |
| 4 |
Amazon
AMZN
|
+$47.8M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$88.7M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$70.5M |
| 3 |
Johnson & Johnson
JNJ
|
+$64.2M |
| 4 |
Apple
AAPL
|
+$62M |
| 5 |
RB Global
RBA
|
+$55.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.88% |
| 2 | Healthcare | 15.94% |
| 3 | Financials | 12.41% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KDNY
1376
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $845K | ﹤0.01% |
69,488
+51,416
| +285% | +$689K |
|
1377
RE/MAX Holdings
RMAX
$198M
| $841K | ﹤0.01% |
25,703
| – | – |
|
|
TSE
1378
DELISTED
Trinseo
TSE
| $841K | ﹤0.01% |
32,800
| – | – |
|
|
MTOR
1379
DELISTED
MERITOR, Inc.
MTOR
| $838K | ﹤0.01% |
40,000
| – | – |
|
|
ECHO
1380
DELISTED
Echo Global Logistics, Inc.
ECHO
| $838K | ﹤0.01% |
32,535
| – | – |
|
|
EQC
1381
DELISTED
Equity Commonwealth
EQC
| $835K | ﹤0.01% |
31,370
+28,340
| +935% | +$876K |
|
|
CHX
1382
DELISTED
ChampionX
CHX
| $833K | ﹤0.01% |
+104,200
| New | +$1M |
|
|
DVAX
1383
DELISTED
Dynavax Technologies
DVAX
| $832K | ﹤0.01% |
+192,594
| New | +$1.37M |
|
1384
Vir Biotechnology
VIR
$1.46B
| $829K | ﹤0.01% |
24,128
+18,578
| +335% | +$800K |
|
|
WIRE
1385
DELISTED
Encore Wire Corp
WIRE
| $829K | ﹤0.01% |
17,867
| – | – |
|
1386
Tennant Co
TNC
$1.47B
| $828K | ﹤0.01% |
13,719
| – | – |
|
1387
Zymeworks
ZYME
$1.62B
| $825K | ﹤0.01% |
+17,701
| New | +$608K |
|
1388
CGI
GIB
$15.6B
| $822K | ﹤0.01% |
11,800
-2,900
| -20% | -$198K |
|
|
SAFE
1389
Safehold
SAFE
$1.19B
| $822K | ﹤0.01% |
14,299
| – | – |
|
|
GRTS
1390
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $822K | ﹤0.01% |
309,853
-363,064
| -54% | -$1.35M |
|
1391
Greif
GEF
$4.87B
| $821K | ﹤0.01% |
22,686
| – | – |
|
1392
NETGEAR
NTGR
$624M
| $820K | ﹤0.01% |
26,617
| – | – |
|
1393
Myriad Genetics
MYGN
$485M
| $819K | ﹤0.01% |
62,798
| – | – |
|
1394
Usana Health Sciences
USNA
$417M
| $818K | ﹤0.01% |
11,100
| – | – |
|
|
TBCH
1395
Turtle Beach Corp
TBCH
$255M
| $814K | ﹤0.01% |
44,752
+16,752
| +60% | +$300K |
|
|
ESPR
1396
DELISTED
Esperion Therapeutics
ESPR
| $812K | ﹤0.01% |
21,855
-3,590
| -14% | -$142K |
|
1397
Innoviva
INVA
$1.6B
| $812K | ﹤0.01% |
77,701
| – | – |
|
1398
Canadian Natural Resources
CNQ
$96B
| $810K | ﹤0.01% |
100,466
-4,084
| -4% | -$36.8K |
|
1399
Suncor Energy
SU
$77.7B
| $809K | ﹤0.01% |
64,574
-6,279
| -9% | -$98.3K |
|
1400
Dyne Therapeutics
DYN
$4.24B
| $808K | ﹤0.01% |
+40,000
| New | +$878K |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2020 Portfolio in Review
As of Q3 2020, Ensign Peak Advisors held 1,779 positions worth $39.6B, up 7.6% from $36.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2020 filing shows 108 new, 532 increased, 495 reduced and 39 closed positions. Its largest new stake was Whiting Petroleum Corporation: 475,126 shares worth $8.21M. The largest sale was Intel, an estimated $88.7M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2020 buy was Whiting Petroleum Corporation: 475,126 shares worth $8.21M.
- Ensign Peak Advisors added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $141M increase.
- Ensign Peak Advisors's biggest Q3 2020 reduction was Intel, cutting an estimated $88.7M.
- Ensign Peak Advisors fully exited Novartis in Q3 2020, selling an estimated $9.96M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $39.6B portfolio in Q3 2020.
- Ensign Peak Advisors opened 108 new positions and closed 39 in Q3 2020.
- Ensign Peak Advisors's portfolio value rose 7.6% quarter-over-quarter to $39.6B.
Based on Ensign Peak Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.